August 2022 “Observational studies registry and sharing protocols – why is that important?”; World Health Organization Monkeypox research: What study designs can be used to address the remaining knowledge gaps for monkeypox vaccines?
June 2022 “Big data during the COVID-19 pandemic”; Jean Goulding Institute Bristol Data Science Week
March 2022 “Association of COVID-19 infection and vaccination with arterial and venous vascular diseases using electronic health records from 48 million adults in England and Wales”; British Heart Foundation Data Science Research Showcase
February 2022 “Findings from the Coronavirus post-acute long-term effects: constructing an evidence base (Convalescence) Study”; Long COVID NHS England Briefing
October 2021 “Predicting drug repurposing opportunities for Alzheimer’s disease prevention using genome-wide association study data”; Methods in longitudinal dementia research (MELODEM) Webinar
June 2021 “Separating the effects of cardiometabolic risk factors from type 2 diabetes on coronary and peripheral artery disease”; Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Webinar
May 2021 “Investigating the effects of renin-angiotensin system drugs on COVID-19 outcomes“; British Heart Foundation Data Science Centre Webinar
January 2020 “Investigating unintended drug effects: what can Mendelian randomization add?”; Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium Meeting; Houston, USA
July 2019 “The consequences of adjusting genome-wide association studies on two-sample Mendelian randomization”; Mendelian Randomization conference; Bristol, UK
August 2018 “Can treatments for hypertension be repurposed for the treatment of dementia?”; International Society of Pharmacoepidemiology annual conference; Prague, Czech Republic
July 2018 “Can treatments for hypertension be repurposed for the treatment of dementia?”; European Congress of Epidemiology annual conference; Lyon, France
June 2018 “Can treatments for hypertension; Society of Epidemiologic Research annual conference be repurposed for the treatment of dementia?”; Baltimore, USA
May 2018 Exhibition stall “Hypertension and Alzheimer’s disease – what is the link?”; Research without borders showcase exhibition; Bristol, UK
May 2018 Panel discussion “Do you know what they know? Challenges in a data-driven world”; Research without Borders evening discussion series, in collaboration with the Jean Goulding Institute; Bristol, UK
April 2018 “Mendelian randomization: a novel approach for the prediction of adverse drug events and drug repurposing opportunities”; International Society for Pharmacoepidemiology mid-year meeting; Toronto, Canada
April 2018 Poster presentation “What is the impact of regulatory guidance and expiry of drug patents on dementia drug prescriptions in England?“; University of Bristol brain research showcase and networking day; Bristol, UK
December 2017 “Predicting drug success using genetic evidence”; University of Bristol biomedical and health sciences industry day; Bristol, UK
June 2017 “Power calculator for instrumental variable analysis in pharmacoepidemiology”; The UK Administrative Data Research Network annual research conference; Edinburgh, UK
December 2016 Poster presentation “Prescribing practice for drugs for dementia in the UK Clinical Practice Research Datalink”; Alzheimer’s Research UK research conference; Aberdeen, UK
December 2016 “Mendelian randomization: a novel approach for the prediction of adverse drug events and drug repurposing opportunities”; University of Bristol population health symposium; Bristol, UK